Apollomics, Inc.

NASDAQ: APLM · Healthcare · Biotechnology

PublicHQ Foster City, CA · San MateoCIK 0001944885Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 35

v0.1 · 5/100 weight · pillars only

↑ market scale, Piotroski F · ↓ filing timeliness, balance-sheet leverage

Methodology →

Revenue TTM

$8.7M

Rev growth YoY (TTM)

+660.3%

Net income (FY)

-$53.9M

Employees

as of 2026-09-19

Market cap

$51.4M

as of 2026-09-19

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$53.9M-$53.9M2024

Total assets$13.1M$13.1M2024

Liabilities$448.1M$448.1M2022

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Apollomics, Inc.’s financial profile?

Apollomics, Inc. earned -$53.9M in FY2024 net income.

Peers · Healthcare

MiNK Therapeutics, Inc.——PDS Biotechnology Corporation——MindWalk Holdings Corp.——Dogwood Therapeutics, Inc.——Werewolf Therapeutics, Inc.——Rocket Doctor AI Inc.——

Neighbors

San Mateo →

Meta Platforms, Inc.$201.0B86A Gilead Sciences, Inc.$29.4B87A Robinhood Markets, Inc.$4.5B67B Equinix, Inc.$9.2B74B Electronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$052D

Key facts

CEOHung-Wen Chen

SectorHealthcare

IndustryBiotechnology

HeadquartersFoster City, CA

ExchangeNASDAQ: APLM

Employees14

IPO date2021-11-26

Latest filings

6-K2026-08-12 6-K2026-07-21 6-K2026-07-14 6-K2026-06-24 6-K2026-04-27 20-F2026-04-24 6-K2026-04-01 6-K2025-12-22

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.